Psoriatic arthritis - Recognition and management

被引:10
作者
Bruce, IN [1 ]
Gladman, DD [1 ]
机构
[1] Toronto Hosp, Ctr Prognosis Studies Rheumat Dis, Western Div, Psoriat Arthrit Clin, Toronto, ON M5T 2S8, Canada
关键词
D O I
10.2165/00063030-199809040-00002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Psoriatic arthritis is an inflammatory arthritis associated with psoriasis, which is usually negative for rheumatoid factor. The disease displays a wide spectrum of articular and periarticular features which may progress with time. Although psoriatic arthritis was thought to be a benign condition, it is now clear that up to 20% of patients progress to significant joint damage and functional disability. Recently, several predictors for progression have been described and suggest the need for earlier, more aggressive, use of therapy in these patients. The ideal treatment for psoriatic arthritis is unclear, and few randomised controlled trials have been reported to date in this condition. Prospective evaluation of the treatment of early disease is now required to assess the effect of current and future therapies on the clinical, radiological and functional outcomes of this condition.
引用
收藏
页码:271 / 278
页数:8
相关论文
共 49 条
[21]  
GLADMAN DD, 1992, J RHEUMATOL, V19, P1724
[22]  
GUPTA AK, 1995, J RHEUMATOL, V22, P894
[23]   Methotrexate and liver toxicity: Role of surveillance liver biopsy [J].
Hassan, W .
ANNALS OF THE RHEUMATIC DISEASES, 1996, 55 (05) :273-275
[24]  
HELLIWELL P, 1991, BRIT J RHEUMATOL, V30, P339
[25]   A DOUBLE-BLIND CONTROLLED TRIAL OF ETRETINATE (TIGASON) AND IBUPROFEN IN PSORIATIC-ARTHRITIS [J].
HOPKINS, R ;
BIRD, HA ;
JONES, H ;
HILL, J ;
SURRALL, KE ;
ASTBURY, C ;
MILLER, A ;
WRIGHT, V .
ANNALS OF THE RHEUMATIC DISEASES, 1985, 44 (03) :189-193
[26]   TREATMENT OF PSORIATIC-ARTHRITIS WITH ORAL 1,25-DIHYDROXYVITAMIN-D3 - A PILOT-STUDY [J].
HUCKINS, D ;
FELSON, DT ;
HOLICK, M .
ARTHRITIS AND RHEUMATISM, 1990, 33 (11) :1723-1727
[27]  
JONES SM, 1994, BRIT J RHEUMATOL, V33, P834
[28]   THE EFFECT OF GLUCOCORTICOIDS ON JOINT DESTRUCTION IN RHEUMATOID-ARTHRITIS [J].
KIRWAN, JR ;
BYRON, M ;
DIEPPE, P ;
EASTMOND, C ;
HALSEY, J ;
HICKLING, P ;
HOLLINGWORTH, P ;
JACOBY, R ;
KIRK, A ;
MORAN, C ;
REID, D ;
SWANNELL, T ;
YATES, D ;
COOPER, C ;
GEORGE, E ;
FORBES, D ;
JESSOP, J ;
WATT, I .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (03) :142-146
[29]  
KLINKHOFF AV, 1989, J RHEUMATOL, V16, P789
[30]   LOW INCIDENCE OF HEPATOTOXICITY ASSOCIATED WITH LONG-TERM, LOW-DOSE ORAL METHOTREXATE IN TREATMENT OF REFRACTORY PSORIASIS, PSORIATIC-ARTHRITIS, AND RHEUMATOID-ARTHRITIS - AN ACCEPTABLE RISK BENEFIT RATIO [J].
LANSE, SB ;
ARNOLD, GL ;
GOWANS, JDC ;
KAPLAN, MM .
DIGESTIVE DISEASES AND SCIENCES, 1985, 30 (02) :104-109